3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Toxemia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Myocarditis
1
Muscle Weakness
1
Melanoma
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Neuroendocrine
1
Carcinoma in Situ
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Specimen Handling
53
pembrolizumab
51
Carboplatin
51
Magnetic Resonance Spectroscopy
46
Pemetrexed
41
Cisplatin
36
Paclitaxel
25
durvalumab
24
osimertinib
22
Nivolumab
22
Gemcitabine
20
Radiosurgery
18
Radiotherapy
17
Docetaxel
17
atezolizumab
15
Immunoglobulin G
15
Biopsy
15
Disulfides
14
130-nm albumin-bound paclitaxel
13
Taxes
12
Radiation
12
Educational Status
12
Etoposide
11
Blood Specimen Collection
11
Early Intervention, Educational
10
Drug Therapy
10
Practice Guidelines as Topic
9
Platinum
9
Methods
9
Cetuximab
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Positron-Emission Tomography
×
90 days
×
Clear all
No trials found.